AquaBounty is a company that raises genetically modified salmon in land-based farms

AquaBounty Technologies is a publicly traded aquaculture company that grows Atlantic salmon in controlled indoor facilities rather than ocean net pens. The company uses a strain of salmon it developed through genetic modification — the fish carry a growth hormone gene from Chinook salmon and a promoter from ocean pout that allows them to grow to market size in roughly half the time of conventional farmed salmon, typically 16 to 18 months instead of three years.

The company operates land-based farms in Indiana and Prince Edward Island, Canada. These facilities use recirculating aquaculture systems (RAS), meaning water is filtered and reused rather than drawn from and returned to natural water bodies. AquaBounty's salmon are sold under the brand name AquAdvantage and are distributed to retailers and food service operations in the United States and Canada.

AquaBounty went public on the NASDAQ in 2016 under the ticker symbol AQB. The company's business model depends on selling fish at a price that covers the cost of land-based facility operation, feed, labor, and the genetic licensing fees built into its production process.

Key Takeaways

  • AquaBounty raises genetically modified Atlantic salmon in indoor recirculating systems, not ocean pens, which means no direct interaction with wild fish populations.
  • The company's salmon reach market weight in 16 to 18 months, roughly half the time of conventional farmed salmon, because of a growth-accelerating genetic modification.
  • AquaBounty operates two land-based farms — one in Indiana and one in Prince Edward Island — and sells fish under the AquAdvantage brand name.
  • The company is regulated by the U.S. Food and Drug Administration as a new animal drug, not as a food product, which is why the salmon required FDA approval before sale.

How AquaBounty's genetic modification works

AquaBounty's salmon contain two genetic insertions. The first is a growth hormone gene taken from Chinook salmon, a larger Pacific species. The second is a promoter — a genetic switch — taken from ocean pout, a cold-water fish. This promoter turns the growth hormone gene on year-round, whereas in conventional salmon the gene is active only during warm months. The result is continuous growth rather than seasonal growth, which shortens the time to market weight.

The modification does not change the salmon's appearance, taste, or nutritional profile in ways that differ from conventional farmed salmon. The fish are sterile — they cannot reproduce — which was a regulatory requirement to prevent genetic material from spreading to wild populations if fish escaped. All AquaBounty salmon are female and triploid, meaning they have three sets of chromosomes instead of two, which renders them unable to breed.

The FDA reviewed the genetic modification and determined in 2015 that AquAdvantage salmon are as safe to eat as conventional salmon. The approval was conditional: AquaBounty must use only sterile female fish, must keep detailed records of all fish and facility operations, and must report any escapes or unusual mortality to the FDA.

Land-based farming versus ocean net pens

AquaBounty's facilities are land-based recirculating systems, which differ fundamentally from the ocean net pens used by most salmon farms. In a recirculating system, water is pumped through biofilters that remove waste and ammonia, then returned to the fish tanks. The same water cycles through the system repeatedly, with only a small percentage replaced daily. This design eliminates direct contact between farmed fish and wild fish or wild water.

Ocean net pens, by contrast, are cages anchored in bays or coastal waters. Water flows through them naturally, which means waste, uneaten feed, and escaped fish can affect the surrounding ecosystem. Sea lice and diseases can spread between farmed and wild fish. AquaBounty's approach avoids these problems but requires significant infrastructure — tanks, pumps, filtration systems, heating, and aeration — all of which consume electricity and require skilled operation.

The trade-off is cost and location. Land-based farms can be built inland, away from ocean access, which is why AquaBounty operates in Indiana. But the operating costs are higher than ocean net pens, which is one reason AquaBounty's salmon commands a premium price at retail.

Regulatory approval and FDA oversight

AquaBounty's salmon was the first genetically modified animal approved for human consumption in the United States. The FDA's approval process took roughly 20 years from initial process to market authorization. The agency classified the salmon as a new animal drug because the genetic modification is the active ingredient that produces the growth effect, even though the fish itself is the food product.

This classification means AquaBounty must comply with FDA regulations for drug manufacturing, not just food safety. The company must maintain detailed records of breeding, genetics, facility conditions, feed, and any health issues. It must report escapes, unusual mortality, and any adverse events to the FDA. The facility itself is subject to FDA inspection.

Canada approved AquaBounty salmon through its own regulatory process, and the fish is sold in Canadian retail and food service channels. The European Union has not approved the salmon, and it is not sold in EU markets. Some U.S. states have passed laws requiring labeling of genetically modified salmon or restricting its sale, though federal law does not currently require labeling.

Where AquaBounty salmon is sold

AquAdvantage salmon is sold in the United States and Canada through conventional retail channels — grocery stores, restaurants, and food service distributors. It is not sold exclusively through specialty or health-focused retailers; it appears in standard supermarket seafood sections alongside conventional farmed and wild-caught salmon. The fish is typically labeled as genetically modified or as AquAdvantage brand salmon, depending on the retailer.

Pricing varies by retailer and region, but AquAdvantage salmon generally costs more per pound than conventional farmed Atlantic salmon because of the higher operating costs of land-based facilities and the licensing fees built into production. It typically costs less than wild-caught salmon.

AquaBounty also sells eggs and juvenile fish to other aquaculture operations that operate their own facilities. This wholesale business is a secondary revenue stream for the company.

AquaBounty's financial performance and market position

AquaBounty is a publicly traded company, so its financial results are reported quarterly to the SEC. The company has been profitable in recent years, though it operated at a loss for many years after going public while scaling production and building its second facility. Revenue comes from fish sales, wholesale egg and juvenile fish sales, and licensing arrangements.

The company competes with conventional salmon farmers, particularly in North America. Its competitive advantage is faster growth time and the elimination of ocean-based environmental concerns. Its disadvantage is higher operating cost, which limits its price competitiveness against large conventional farms in Norway, Chile, and Canada that benefit from economies of scale and lower labor costs.

AquaBounty has announced plans to expand production capacity and to build additional facilities, though the timeline and location of future expansion depend on market demand, regulatory approval in new jurisdictions, and capital availability.

Environmental and food safety considerations

Land-based recirculating systems eliminate several environmental concerns associated with ocean net pen farming: no escape risk to wild populations (because fish are sterile and contained), no sea lice transmission, no nutrient pollution of coastal waters, and no interaction with wild fish. However, they create different environmental impacts: high electricity consumption for pumps and temperature control, wastewater discharge (even recirculating systems must replace some water), and the energy footprint of facility construction and operation.

Food safety is managed through FDA oversight and AquaBounty's own quality control. The fish are raised in controlled conditions with no exposure to wild pathogens, which some argue reduces disease risk compared to ocean farming. However, the closed system also means any disease outbreak within a facility could affect a large number of fish at once, whereas ocean farms are more dispersed.

Consumer acceptance has grown gradually since FDA approval. Some consumers prefer the environmental profile of land-based farming; others prefer wild-caught salmon or are skeptical of genetic modification. Retailers stock the product based on customer demand and their own sourcing policies.

Frequently Asked Questions

Is AquaBounty salmon safe to eat?

The FDA determined in 2015 that AquAdvantage salmon is as safe as conventional salmon. The agency reviewed the genetic modification, the fish's composition, and the facility's safety protocols before approval. The salmon has been sold in the U.S. and Canada for years with no reported safety incidents. Individual consumers may have different comfort levels with genetically modified food, but food safety data does not distinguish it from conventional farmed salmon.

How can I tell if salmon at the store is from AquaBounty?

AquAdvantage salmon is labeled as such or marked as genetically modified, depending on the retailer's labeling practice. Some stores place it in a separate section or note it on the price tag. You can ask the seafood counter staff which salmon is AquAdvantage, or check the package label. Not all stores carry it, so availability varies by location and retailer.

Why does AquaBounty salmon cost more than regular farmed salmon?

Land-based recirculating facilities have higher operating costs than ocean net pens: electricity for pumps and temperature control, facility maintenance, skilled labor, and water treatment. These costs are passed to the consumer. The faster growth time reduces feed costs per fish, but not enough to offset the facility expenses, so the fish sells at a premium to conventional farmed salmon.

Can AquaBounty salmon escape and breed with wild salmon?

No. All AquaBounty salmon are sterile and triploid, meaning they cannot reproduce. This was a regulatory requirement to prevent genetic material from spreading to wild populations. The fish are also raised in contained land-based facilities, not ocean pens, so escape risk is minimal. If an escape did occur, the fish could not breed.

Is AquaBounty salmon available everywhere in North America?

No. Availability depends on retailer sourcing decisions and state or provincial regulations. Some U.S. states have labeling or sales restrictions on genetically modified salmon. Availability is highest in major metropolitan areas and in Canada, where regulatory approval came earlier. You may need to call ahead or ask your local seafood counter whether they stock it.